162 related articles for article (PubMed ID: 11564173)
1. Variable CD7 expression on T cells in the leukemic phase of cutaneous T cell lymphoma (Sézary syndrome).
Vonderheid EC; Bigler RD; Kotecha A; Boselli CM; Lessin SR; Bernengo MG; Polansky M
J Invest Dermatol; 2001 Sep; 117(3):654-62. PubMed ID: 11564173
[TBL] [Abstract][Full Text] [Related]
2. Skewed expression of activation, differentiation and homing-related antigens in circulating cells from patients with cutaneous T cell lymphoma associated with CD7- T helper lymphocytes expansion.
Scala E; Russo G; Cadoni S; Narducci MG; Girardelli CR; De Pità O; Puddu P
J Invest Dermatol; 1999 Oct; 113(4):622-7. PubMed ID: 10504451
[TBL] [Abstract][Full Text] [Related]
3. Immunophenotypic identification of Sezary cells in peripheral blood.
Bogen SA; Pelley D; Charif M; McCusker M; Koh H; Foss F; Garifallou M; Arkin C; Zucker-Franklin D
Am J Clin Pathol; 1996 Dec; 106(6):739-48. PubMed ID: 8980349
[TBL] [Abstract][Full Text] [Related]
4. CD7-positive Sézary syndrome with a Th1 cytokine profile.
Yagi H; Tokura Y; Furukawa F; Takigawa M
J Am Acad Dermatol; 1996 Feb; 34(2 Pt 2):368-74. PubMed ID: 8655729
[TBL] [Abstract][Full Text] [Related]
5. Detection of circulating T cells with CD4+CD7- immunophenotype in patients with benign and malignant lymphoproliferative dermatoses.
Harmon CB; Witzig TE; Katzmann JA; Pittelkow MR
J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):404-10. PubMed ID: 8784277
[TBL] [Abstract][Full Text] [Related]
6. Utility of flow cytometry immunophenotyping and DNA ploidy studies for diagnosis and characterization of blood involvement in CD4+ Sézary's syndrome.
Lima M; Almeida J; dos Anjos Teixeira M; Queiros ML; Santos AH; Fonseca S; Balanzategui A; Justica B; Orfao A
Haematologica; 2003 Aug; 88(8):874-87. PubMed ID: 12935975
[TBL] [Abstract][Full Text] [Related]
7. Absence of CD26 expression on skin-homing CLA+ CD4+ T lymphocytes in peripheral blood is a highly sensitive marker for early diagnosis and therapeutic monitoring of patients with Sézary syndrome.
Sokolowska-Wojdylo M; Wenzel J; Gaffal E; Steitz J; Roszkiewicz J; Bieber T; Tüting T
Clin Exp Dermatol; 2005 Nov; 30(6):702-6. PubMed ID: 16197392
[TBL] [Abstract][Full Text] [Related]
8. CD4+CD7- leukemic T cells from patients with Sézary syndrome are protected from galectin-1-triggered T cell death.
Rappl G; Abken H; Muche JM; Sterry W; Tilgen W; André S; Kaltner H; Ugurel S; Gabius HJ; Reinhold U
Leukemia; 2002 May; 16(5):840-5. PubMed ID: 11986945
[TBL] [Abstract][Full Text] [Related]
9. Association of change in clinical status and change in the percentage of the CD4+CD26- lymphocyte population in patients with Sézary syndrome.
Introcaso CE; Hess SD; Kamoun M; Ubriani R; Gelfand JM; Rook AH
J Am Acad Dermatol; 2005 Sep; 53(3):428-34. PubMed ID: 16112348
[TBL] [Abstract][Full Text] [Related]
10. Determination of immunophenotypic aberrancies provides better assessment of peripheral blood involvement by mycosis fungoides/Sézary syndrome than quantification of CD26- or CD7- CD4+ T-cells.
Lyapichev KA; Bah I; Huen A; Duvic M; Routbort MJ; Wang W; Jorgensen JL; Medeiros LJ; Vega F; Craig FE; Wang SA
Cytometry B Clin Cytom; 2021 Mar; 100(2):183-191. PubMed ID: 32667737
[TBL] [Abstract][Full Text] [Related]
11. CD4 + /CD7- T cell frequency and polymerase chain reaction-based clonality assay correlate with stage in cutaneous T cell lymphomas.
Laetsch B; Häffner AC; Döbbeling U; Seifert B; Ludwig E; Burg G; Dummer R
J Invest Dermatol; 2000 Jan; 114(1):107-11. PubMed ID: 10620124
[TBL] [Abstract][Full Text] [Related]
12. Stage-dependent expression of CD7, CD45RO, CD45RA and CD25 on CD4-positive peripheral blood T-lymphocytes in cutaneous T-cell lymphoma.
Jakob T; Neuber K; Altenhoff J; Kowalzick L; Ring J
Acta Derm Venereol; 1996 Jan; 76(1):34-6. PubMed ID: 8721488
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of lymphocyte interleukin-12 receptor expression in Sézary syndrome.
Zaki MH; Shane RB; Geng Y; Showe LC; Everetts SE; Presky DH; Wysocka M; Moore JS; Rook AH
J Invest Dermatol; 2001 Jul; 117(1):119-27. PubMed ID: 11442758
[TBL] [Abstract][Full Text] [Related]
14. Quantitative flow cytometric identification of aberrant T cell clusters in erythrodermic cutaneous T cell lymphoma. Implications for staging and prognosis.
Horna P; Deaver DM; Qin D; Moscinski LC; Sotomayor EM; Glass LF; Sokol L
J Clin Pathol; 2014 May; 67(5):431-6. PubMed ID: 24319102
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of genetically defined tumor cells in CD7 as well as CD26 positive and negative circulating T-cell subsets in Sézary syndrome.
Steinhoff M; Schöpp S; Assaf C; Muche M; Beyer M; Sterry W; Lukowsky A
Leuk Res; 2009 Jan; 33(1):88-99. PubMed ID: 18672285
[TBL] [Abstract][Full Text] [Related]
16. CD7 expression in reactive and malignant human skin T-lymphocytes.
Alaibac M; Pigozzi B; Belloni-Fortina A; Michelotto A; Saponeri A; Peserico A
Anticancer Res; 2003; 23(3B):2707-10. PubMed ID: 12894562
[TBL] [Abstract][Full Text] [Related]
17. CD4(+)CD7(-) T cells compose the dominant T-cell clone in the peripheral blood of patients with Sézary syndrome.
Rappl G; Muche JM; Abken H; Sterry W; Tilgen W; Ugurel S; Reinhold U
J Am Acad Dermatol; 2001 Mar; 44(3):456-61. PubMed ID: 11209115
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD164 on Malignant T cells in Sézary Syndrome.
Guenova E; Ignatova D; Chang YT; Contassot E; Mehra T; Saulite I; Navarini AA; Mitev V; Dummer R; Kazakov DV; French LE; Hoetzenecker W; Cozzio A
Acta Derm Venereol; 2016 May; 96(4):464-7. PubMed ID: 26524186
[TBL] [Abstract][Full Text] [Related]
19. Evidence for restricted Vbeta usage in the leukemic phase of cutaneous T cell lymphoma.
Vonderheid EC; Boselli CM; Conroy M; Casaus L; Espinoza LC; Venkataramani P; Bigler RD; Hou JS
J Invest Dermatol; 2005 Mar; 124(3):651-61. PubMed ID: 15737208
[TBL] [Abstract][Full Text] [Related]
20. Leu-8/CD7 antigen expression by CD3+ T cells: comparative analysis of skin and blood in mycosis fungoides/Sézary syndrome relative to normal blood values.
Wood GS; Hong SR; Sasaki DT; Abel EA; Hoppe RT; Warnke RA; Morhenn VB
J Am Acad Dermatol; 1990 Apr; 22(4):602-7. PubMed ID: 1690762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
